Passez à l'illimité avec Magzter GOLD
Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement
Essayer OR - Gratuit
Sanofi bags GCC Workplace Awards 2025
Chronicle Pharmabiz
|July 17, 2025
SANOFI Global Services received two accolades that highlight its leadership in the global capability centre (GCC) landscape at the recently concluded Zyoin Group GCC Workplace Summit and Awards2025, held in Bengaluru.
Sanofi was recognized as the “Top GCC of 2025”, celebrating its excellence in innovation, workplace culture, and strategic impact across global operations. In a remarkable individual honour, Mrinal Duggal, head of Sanofi, Hyderabad, was named “GCC Country Leader of the Year”, in recognition of her exceptional leadership and contributions to strengthening Sanofi’s global trans
Cette histoire est tirée de l'édition July 17, 2025 de Chronicle Pharmabiz.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Chronicle Pharmabiz
Chronicle Pharmabiz
Devices sector raises concern over notification proposing fee for tests
THE medical devices industry has raised concern over the Department of Health and Family Welfares' draft notification introducing fee for test or evaluation of medical devices and mandating inclusion of licence number of sub contractor on the product labels. The Department published the draft notification on April 10, proposing various amendments to the Medical Devices Rules (MDR), 2017 including introduction of fee for test or evaluation of 11 types of tests or evaluation.
2 mins
April 30, 2026
Chronicle Pharmabiz
Panel asks DoP to take efforts to decrease imported content in medical devices
OBSERVING that a majority of the medical devices market is addressed by imports, the Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceuticals (DOP) to take measures including promotion of stronger collaboration among the industry, academic institutions and research organisations to accelerate indigenous development of advanced medical devices.
1 mins
April 30, 2026
Chronicle Pharmabiz
AI in endoscopy will improve detecting early-stage cancer markers
INDIA has been moving steadily towards better cancer care. However, many cancers in India are still detected late, especially those in the digestive system.
2 mins
April 30, 2026
Chronicle Pharmabiz
Telangana appoints DG of DCA as compounding authority
IN a significant move to streamline regulatory compliance under the newly enacted Jan Vishwas provisions, the Government of Telangana has officially designated the Director General (DG) of the state’s Drugs Control Administration (DCA), Shahnawas Quasim, as the 'Compounding Authority'.
2 mins
April 30, 2026
Chronicle Pharmabiz
AIOCD seeks PM's intervention against e-pharmacies
THE All India Organisation of Chemists & Druggists (AIOCD), representing over 12.40 lakh pharmacists and distributors, has formally petitioned Prime Minister Narendra Modi to intervene against the unregulated growth of e-pharmacies and predatory pricing by large corporate entities.
1 mins
April 30, 2026
Chronicle Pharmabiz
Shed The Cavalier Attitude
A Parliamentary Panel has recently asked the Department of Pharmaceuticals (DoP) to take corrective steps to remove any administrative and procedural delays related to the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme.
2 mins
April 30, 2026
Chronicle Pharmabiz
DCOIWA slams new DCGI recruitment rules, cites dilution of tech standards
THE Drugs Control Officers (I) Welfare Association (DCOIWA), the national body of drug regulatory officers in the country, has criticised the Union Heath Ministry's newly notified recruitment rules for the post of DCGI, labelling them as a serious policy lapse.
1 mins
April 30, 2026
Chronicle Pharmabiz
Experts highlight the need for data exclusivity to protect MSMES
EXPERTS have highlighted the need for clinical data exclusivity in order to protect MSME drug innovators in India.
2 mins
April 30, 2026
Chronicle Pharmabiz
Mid-sized hospitals in Tier-2 cities stranded in a financial vacuum: Expert
MID-sized hospitals in Tier-2 cities are currently trapped in a financial vacuum. This is because funding usually arrives either too early as venture capital or too late as a financial buyout, said Rakshith Rangarajan, equity fund manager, Inviga Investment Advisors.
2 mins
April 30, 2026
Chronicle Pharmabiz
Indian healthcare sector faces escalating cyber risks
INDIAN healthcare sector is confronting a surge in cyber threats as increasingly complex hospital IT ecosystems create multiple vulnerabilities for potential breaches.
2 mins
April 30, 2026
Listen
Translate
Change font size